Skip to main content
Market intelligence
ANIXHealthcare

Anixa Biosciences Inc insider activity

In the last 90 days, 2 corporate insiders purchased $189,148 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
1
90-day purchase value
$189,148
Corporate buyers
2
Latest transaction
Sep 10, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 10, 2026Amit KumarChief Executive OfficerOpen Market Purchase3,000$2.75$8,250
Sep 10, 2026Lewis H Titterton jrCorporate insiderOpen Market Purchase10,000$2.73$27,300
Sep 10, 2026Amit KumarChief Executive OfficerOpen Market Purchase5,000$2.76$13,800